Quotient QTNT shares are trading higher on Monday, after the company announced the completion of its coronavirus antibodies test development.
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide.
Quotient shares were trading up 19.97% at $4.48 on Monday. The stock has a 52-week high of $11.30 and a 52-week low of $2.40.
Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
